State-wide surveillance of in-hospital antimicrobial utilisation in South Australia
DOI:
https://doi.org/10.33321/cdi.2003.27.16Keywords:
antimicrobial utilisation, cephalosporin, carbapenem, glycopeptide, fluoroquinolone, antibiotic resistanceAbstract
In late 2001, a group of South Australian metropolitan public and private hospitals commenced voluntary contribution of data on in-hospital utilisation of antimicrobials to the Communicable Disease Control Branch of the Department of Human Services. Where possible, hospitals contributed data on all antimicrobials dispensed for use within the institution each month. These data were stratified into antimicrobials issued to intensive care units and antimicrobials issued to all other areas within the hospital. In the first instance, only data relating to four antimicrobial classes have been analysed. These classes are third or fourth generation cephalosporins, carbapenems, glycopeptides and fluoroquinolones. Utilisation of these four classes was presented as a monthly utilisation rate i.e., total defined daily doses for each antimicrobial class per month per 1,000 occupied bed days. These utilisation rates were calculated for each individual hospital and for the combined group of contributing hospitals (state-wide rate). Although limited data are currently available, results to date demonstrate a much higher antimicrobial usage rate in intensive care units than other in-patient areas for the classes currently analysed. Considerable variation in the usage of various antimicrobials has been noted for individual hospitals, and analysis of trends over a longer time period, in conjunction with resistance surveillance data, will be required. Commun Dis Intell 2003;27 Suppl:S19-S27.
Downloads
References
Centers for Disease Control and Prevention campaign to prevent antimicrobial resistance in health-care settings. MMWR Morb Mortal Wkly Rep 2002;51:343.
Emmer CL, Besser RE. Combating antimicrobial resistance: intervention programs to promote appropriate antibiotic use. Infect Med 2002;19:160-173.
Sbarbaro JA. Can we influence prescribing patterns? Clin Infect Dis 2001;33 Suppl 3:S240-S244.
Watson DA. Antibiotic guidelines: improved implementation is the challenge. Med J Aust 2002;176:513-514.
Bell DM. Promoting appropriate antimicrobial drug use: perspective from the Centers for Disease Control and Prevention. Clin Infect Dis 2001;33;Suppl 3:S245-S250.
Wilton P, Smith R, Coast J, Millar M. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness. J Health Serv Res Policy 2002;7:111-117.
Empey KM, Rapp RP, Evans ME. The effect of an antimicrobial formulary change on hospital resistance patterns. Pharmacotherapy 2002;22;81-87.
Lawton RM, Fridkin SK, Gaynes RP, McGowan JE Jr. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America. Infect Control Hosp Epidemiol 2000;21:256-259.
Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999;28:1062-1066
MacGowan AP. Role of pharmacokinetics and pharmacodynamics: Does the dose matter? Clin Infect Dis 2001;33 Suppl 3:S238-S239.
Craig WA. Does the dose Matter? Clin Infect Dis 2001;33 Suppl 3:S233-S237.
World Health Organization consultation on global principles for the containment of antimicrobial resistance due to antimicrobial use in livestock. Geneva, June 2000. Available from: http://www.who.int./emc/diseases/zoo/drafting.html
World Health Organization global strategy for containment of antimicrobial resistance. Geneva, June 2001. Available from: http://www.who.int/emc/amrpdfs/WHO_Global_Strategy_English.pdf
The Copenhagen Recommendations: Report from the Invitational European Union Conference on The Microbial Threat. Copenhagen: Ministry of Food, Agriculture and Fisheries. September 1998:1-52. Available from: http://www.tour.info.fr/tours/pap/articles/copen2.htm
Centers for Disease Control and Prevention. A public health action plan to combat antibiotic resistance. June 2000. Available from: http://www.cdc.gov/drugresistance/actionplan/html/index.htm
European Surveillance of Antimicrobial Consumption. ESAC project description. Laboratory of Microbiology, University of Antwerp. Available from: http://www.uia.ac.be/esac/ESAC_project.htm Accessed: 2002.
Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald Lk, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999;29:245-252.
Commonwealth Department of Health and Aged Care. The use of antibiotics in food-producing animals: antibiotic-resistant bacteria in animals and humans. Commonwealth Department of Health and Aged Care, Commonwealth Department of Agriculture, Fisheries and Forestry-Australia. October 1999.
Commonwealth Department of Health and Aged Care. Commonwealth Government response to the report of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR). Commonwealth Department of Health and Aged Care, Commonwealth Department of Agriculture, Fisheries and Forestry-Canberra, August 2000.
Monnet DL, Archibald LK, Phillips L, Tenovar FC, McGowan JE Jr, Gaynes RP. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modelling. Intensive Care Antimicrobial Resistance. Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol 1998;19:388-394.
World Health Organization Collaborative Centre for Drug Statistics Methodology. Available from: http://www.whocc.no/atcddd Accessed: 2002.
Monnet DL, Lopez-Lozano JM, Campillos P, Burgos A, Gonzalo N. Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect 2001;7 Suppl 5:S29-S36
Lopez-Lozano JM, Monnet DL, Yague A, Burgos A, Gonzalo N, Campillos P, et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents 2000;14:21-31.
Downloads
Published
How to Cite
License
Copyright (c) 2003 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
